Male neonates with CHH exhibit persistently low circulating levels of LH, FSH, testosterone, AMH, and inhibin B throughout the mini-puberty window, which extends from approximately the second week of life to six months of age. Here, BRD2 is linked to cartilage-hair hypoplasia.